Breelib nebulizer ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

---

Clinical trials : 1,181 /  Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03293407 (ClinicalTrials.gov)	February 1, 2018	20/9/2017	Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension	Ventavis® (Iloprost): Evaluation of Inhaled Iloprost Effects Using the Breelib™ Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension	Hypertension, Pulmonary	Drug: Iloprost (Ventavis, BAYQ6256);Device: Breelib nebulizer	Bayer	NULL	Completed	18 Years	N/A	All	31		Germany
2	NCT03365479 (ClinicalTrials.gov)	May 1, 2017	27/11/2017	Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension	Acute Hemodynamic Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension	Pulmonary Hypertension;Pulmonary Arterial Hypertension	Drug: Iloprost	University of Giessen	NULL	Completed	18 Years	N/A	All	30	N/A	Germany